Chronic heart failure and depression: The limitations of specialization-specific multidisciplinary guidelines;Chronisch hartfalen en depressie: Beperkingen van specialisme-specifieke multidisciplinaire richtlijnen

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 47, 2004, Pages 2312-2314

  Huyse, F J ^a,b   Slaets, J P J ^c   De Jonge, P ^c   Ormel, J ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DEPRESSION; EPIDEMIOLOGICAL DATA; HEART FAILURE; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; MEDICAL LITERATURE; MORTALITY; NETHERLANDS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT;

CARDIOLOGY; DEPRESSION; HEART FAILURE, CONGESTIVE; HUMANS; INTERDISCIPLINARY COMMUNICATION; NETHERLANDS; PRACTICE GUIDELINES; PSYCHIATRY;

EID: 9244253147     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Richtlijn Stemmingsstoornissen. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO [ter perse].
2. Nederlandse Vereniging voor Cardiologie. Multidisciplinaire richtlijn Chronisch hartfalen. Alphen aan den Rijn: Van Zuiden Communications; 2002.
3. Deuschle M. Depression and cardiovascular disease. In: Thakore JH, editor. Physical consequences of depression. Petersfield: Wrightson Biomedical Publishing; 2001. p. 125-53.
4. Murray CJ, Lopez AD. Global, mortality, disability, and contribution of risk factors: global burden of disease study. Lancet 1997;349:1436-42.
5. Wulsin LR. A systematic review of the mortality of depression. Psychosomatic Med 1999;61:6-17.
6. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-25.
7. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999;84:348-50.
8. Skotzko CE, Krichten C, Zietowski G, Alves L, Freudenberger R, Robinson S, et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail 2000;6:300-5.
9. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch Gen Psychiatry 1998;55:580-92.
10. Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail 2003;9:163-9.
11. Penninx BW, Beekman ATF, Honig A, Deeg DJ, Schoevers RA, Eijk JTM van, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-7.
12. Jonge P de, Ormel J, Slaets JP, Kempen GI, Ranchor AV, Jaarsveld CH van, et al. Depressive symptoms in elderly patients predict poor adjustment after somatic events. Am J Geriatr Psychiatry 2004;12:57-64.
13. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
14. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger jr JT, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
15. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-16.
16. Brink RH van den, Melle JP van, Honig A, Schene AH, Crijns HJ, Lambert FP, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial Infarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002;144:219-25.
17. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek VM, et al. 'Stress' and coronary heart disease: psychosocial risk factors. Med J Aust 2003;178:272-6.
18. Voellinger R, Berney A, Baumann P, Annoni JM, Bryois C, Buclin T, et al. Major depressive disorder in the general hospital: adaptation of clinical practice guidelines. Gen Hosp Psychiatry 2003;25:185-93.
19. Gill D, Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. J Psychosom Res 1999;47:131-43.
20. Glassman AH. Clinical management of cardiovascular risks during treatment with psychotropic drugs. J Clin Psychiatry 2002;63 Suppl 9:12-7.
21. Strain JJ, Karim A, Caliendo G, Alexis JD, Lowe 3rd RS, Fuster V. Cardiac drug - psychotropic drug update. Gen Hosp Psychiatry 2002;24:283-9.
22. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendation for a call to action. A statement for healthcare professionals. Circulation 1997;95:1085-90.
23. Slaets JPJ, Huyse FJ, Gans ROB. Onfortuinlijke gezondheidszorg. Med Contact 2003;40:1519-22.
24. Institute of Medicine (IOM). Crossing the quality chasm: a new health system for the 21st century. Committee on Quality of Health Care in America. Washington, DC: National Academy Press; 2001.
25. Heijmans MJWM, Rijken PM, Schellevis FG, Bos GAM van den. Meer dan een ziekte: de gevolgen van comorhiditeit vanuit het perspectief van chronisch zieken en gehandicapten. Amsterdam: Nivel; 2003.
26. Jackson R, Feder G. Guidelines for clinical guidelines. BMJ 1998;317:427-8.
27. Thomson R, Lavender M, Madhok R. How to ensure that guidelines are effective. BMJ 1995;311:237-42.